Published by Michele Maatouk on 13th January 2025
(Sharecast News) - Johnson & Johnson confirmed on Monday that it has agreed to buy biopharmaceutical firm Intra-Cellular Therapies for around $14.6bn.
URL: http://www.digitallook.com/dl/news/story/34807525/...